Mirova’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.99M Buy
35,821
+32,097
+862% +$4.49M 0.2% 117
2025
Q4
$457K Sell
3,724
-311
-8% -$37.8K 0.07% 81
2025
Q3
$448K Hold
4,035
0.06% 95
2025
Q2
$447K Buy
4,035
+1,140
+39% +$121K 0.06% 99
2025
Q1
$324K Buy
+2,895
New +$299K 0.06% 106
2024
Q4
Sell
-40,232
Closed -$3.37M 130
2024
Q3
$3.37M Hold
40,232
0.58% 42
2024
Q2
$2.76M Hold
40,232
0.5% 49
2024
Q1
$2.95M Buy
+40,232
New +$3.09M 0.52% 43
2023
Q3
Sell
-2,168
Closed -$167K 137
2023
Q2
$167K Sell
2,168
-3,611
-62% -$288K 0.03% 126
2023
Q1
$479K Buy
+5,779
New +$479K 0.07% 110
2021
Q4
Sell
-4,669
Closed -$326K 191
2021
Q3
$326K Buy
4,669
+412
+10% +$28.9K 0.04% 126
2021
Q2
$293K Hold
4,257
0.04% 126
2021
Q1
$275K Sell
4,257
-14,462
-77% -$933K 0.03% 124
2020
Q4
$1.09M Buy
18,719
+3,004
+19% +$181K 0.14% 55
2020
Q3
$993K Sell
15,715
-28
-0.2% -$1.94K 0.16% 41
2020
Q2
$1.21M Buy
15,743
+3,265
+26% +$250K 0.28% 36
2020
Q1
$933K Buy
12,478
+5,196
+71% +$359K 0.35% 30
2019
Q4
$473K Sell
7,282
-235,015
-97% -$15.3M 0.16% 38
2019
Q3
$15.4M Sell
242,297
-135,084
-36% -$8.83M 1.89% 16
2019
Q2
$25.5M Buy
377,381
+374,438
+12,723% +$24.6M 2.25% 14
2019
Q1
$191K Sell
2,943
-21,927
-88% -$1.46M 0.1% 47
2018
Q4
$1.56M Buy
+24,870
New +$1.74M 0.71% 23

Other funds holding GILD

Mirova's GILD Position: Q1 2026 in Review

Mirova increased its Gilead Sciences (GILD) stake by 862% in Q1 2026, buying an estimated $4.49M and bringing the position to 35,821 shares worth $4.99M. The position accounts for 0.2% of the portfolio, ranked #117.

Mirova first reported a position in GILD in Q4 2018 and has held it in 22 quarters since. The position peaked at $25.5M in Q2 2019. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Mirova held 35,821 shares of Gilead Sciences worth $4.99M as of Q1 2026.
  • Mirova bought 32,097 Gilead Sciences shares in Q1 2026, an estimated $4.49M.
  • Gilead Sciences made up 0.2% of Mirova's portfolio in Q1 2026, its #117 holding.
  • Mirova first reported a position in Gilead Sciences in Q4 2018 and has held it in 22 quarters since.
  • Mirova's Gilead Sciences position peaked at $25.5M in Q2 2019.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mirova's 13F filing for Q1 2026, filed 14 May 2026.